The Biotech Investor: How to Profit from the Coming Boom in Biotechnology

3.6 avg rating
( 10 ratings by Goodreads )
 
9780805075083: The Biotech Investor: How to Profit from the Coming Boom in Biotechnology
View all copies of this ISBN edition:
 
 

"Tom Abate's reporting on biotechnology has always been ahead of the times. The Biotech Investor tackles the brave new world of stem cells, genomics, and clones and comes up a winner." ―Thom Calandra, editor in chief, CBS MarketWatch

In The Biotech Investor, San Francisco Chronicle biotechnology reporter Tom Abate explains the science, finances, time horizon, and technological and commercial potential of this burgeoning industry.
Abate provides guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He shares strategies for
· tracking the effect of breaking news and the NASDAQ
· anticipating drug trial announcements and FDA approvals
· assessing the potential market, patent rights, and distribution deals for a drug
He looks beyond medicine to biotech-related opportunities in everything from agriculture to jean manufacturing to software development. The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century's most promising industries.

"synopsis" may belong to another edition of this title.

About the Author:

One of the nation's most influential observers of the biotechnology industry, award-winning technology and health-care reporter Tom Abate writes the weekly "BioScope" column for the San Francisco Chronicle. He lives in San Leandro, California.

From Publishers Weekly:

With the population aging and eager for medical innovations, the market for biotechnology is vast. But for investors looking at biotech firms, it can be a minefield: before a company’s brilliant ideas pan out as profitable products, they must go through years of costly research and development, clear government regulatory hurdles and sometimes, as with genetically modified foods, weather political controversy. This informative and well-written primer will help individual investors navigate the treacherous terrain of biotech stocks. Abate, a biotechnology and health care reporter for the San Francisco Chronicle, provides an overview of each sector of the biotechnology industry and the leading companies in it, tells where to find up-to-date information on the scientific and medical developments that drive the market, and explains how to evaluate the financial prospects of the often shaky start-ups that crowd the field. His advice is appropriately cautious; he suggests putting no more than 20% of a portfolio in biotechnology, and waiting until a company is in hailing distance of profitability before investing. While the book is pitched at the non-professional, Abate makes it clear that these speculative, volatile and often over-sold stocks demand more effort—he recommends reading scientific journals, attending conferences and perusing the patent literature —than a complacent mutual-fund investor is used to. But for those willing to brave the new world of biotechnology, this is a good place to start. 20 charts and graphs.
Copyright 2003 Reed Business Information, Inc.

"About this title" may belong to another edition of this title.

Other Popular Editions of the Same Title

9780805070699: The Biotech Investor: How to Profit from the Coming Boom in Biotechnology

Featured Edition

ISBN 10:  0805070699 ISBN 13:  9780805070699
Publisher: Times Books, 2003
Hardcover

Top Search Results from the AbeBooks Marketplace

1.

Abate, Tom
Published by Holt Paperbacks
ISBN 10: 0805075089 ISBN 13: 9780805075083
New PAPERBACK Quantity Available: 15
Seller:
Lakeside Books
(Benton Harbor, MI, U.S.A.)
Rating
[?]

Book Description Holt Paperbacks. PAPERBACK. Condition: New. 0805075089 BRAND NEW, GIFT QUALITY! NOT OVERSTOCKS OR MARKED UP REMAINDERS! DIRECT FROM THE PUBLISHER!|0.85. Seller Inventory # OTF-Y-9780805075083

More information about this seller | Contact this seller

Buy New
US$ 13.70
Convert Currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, Rates & Speeds

2.

Abate, Tom
Published by St. Martins Press-3pl 1/1/2004 (2004)
ISBN 10: 0805075089 ISBN 13: 9780805075083
New Paperback or Softback Quantity Available: 10
Seller:
BargainBookStores
(Grand Rapids, MI, U.S.A.)
Rating
[?]

Book Description St. Martins Press-3pl 1/1/2004, 2004. Paperback or Softback. Condition: New. The Biotech Investor: How to Profit from the Coming Boom in Biotechnology. Book. Seller Inventory # BBS-9780805075083

More information about this seller | Contact this seller

Buy New
US$ 17.75
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

3.

Abate, Tom
Published by Holt Paperbacks (2018)
ISBN 10: 0805075089 ISBN 13: 9780805075083
New Paperback Quantity Available: > 20
Print on Demand
Seller:
Murray Media
(North Miami Beach, FL, U.S.A.)
Rating
[?]

Book Description Holt Paperbacks, 2018. Paperback. Condition: New. Never used! This item is printed on demand. Seller Inventory # 0805075089

More information about this seller | Contact this seller

Buy New
US$ 18.20
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

4.

Tom Abate
Published by Henry Holt Company Inc, United States (2004)
ISBN 10: 0805075089 ISBN 13: 9780805075083
New Paperback Quantity Available: 10
Print on Demand
Seller:
Book Depository International
(London, United Kingdom)
Rating
[?]

Book Description Henry Holt Company Inc, United States, 2004. Paperback. Condition: New. Reprint. Language: English . Brand New Book ***** Print on Demand *****. Tom Abate s reporting on biotechnology has always been ahead of the times. The Biotech Investor tackles the brave new world of stem cells, genomics, and clones and comes up a winner. --Thom Calandra, editor in chief, CBS MarketWatch In The Biotech Investor, San Francisco Chronicle biotechnology reporter Tom Abate explains the science, finances, time horizon, and technological and commercial potential of this burgeoning industry. Abate provides guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He shares strategies for - tracking the effect of breaking news and the NASDAQ - anticipating drug trial announcements and FDA approvals - assessing the potential market, patent rights, and distribution deals for a drug He looks beyond medicine to biotech-related opportunities in everything from agriculture to jean manufacturing to software development. The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century s most promising industries. Seller Inventory # AAV9780805075083

More information about this seller | Contact this seller

Buy New
US$ 18.39
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

5.

Tom Abate
Published by Henry Holt and Company Inc (2004)
ISBN 10: 0805075089 ISBN 13: 9780805075083
New Quantity Available: > 20
Print on Demand
Seller:
Pbshop
(Wood Dale, IL, U.S.A.)
Rating
[?]

Book Description Henry Holt and Company Inc, 2004. PAP. Condition: New. New Book. Shipped from US within 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # IQ-9780805075083

More information about this seller | Contact this seller

Buy New
US$ 14.79
Convert Currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, Rates & Speeds

6.

Tom Abate
Published by Henry Holt Company Inc, United States (2004)
ISBN 10: 0805075089 ISBN 13: 9780805075083
New Paperback Quantity Available: 10
Print on Demand
Seller:
The Book Depository
(London, United Kingdom)
Rating
[?]

Book Description Henry Holt Company Inc, United States, 2004. Paperback. Condition: New. Reprint. Language: English . Brand New Book ***** Print on Demand *****. Tom Abate s reporting on biotechnology has always been ahead of the times. The Biotech Investor tackles the brave new world of stem cells, genomics, and clones and comes up a winner. --Thom Calandra, editor in chief, CBS MarketWatch In The Biotech Investor, San Francisco Chronicle biotechnology reporter Tom Abate explains the science, finances, time horizon, and technological and commercial potential of this burgeoning industry. Abate provides guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He shares strategies for - tracking the effect of breaking news and the NASDAQ - anticipating drug trial announcements and FDA approvals - assessing the potential market, patent rights, and distribution deals for a drug He looks beyond medicine to biotech-related opportunities in everything from agriculture to jean manufacturing to software development. The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century s most promising industries. Seller Inventory # AAV9780805075083

More information about this seller | Contact this seller

Buy New
US$ 18.87
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

7.

Tom Abate
Published by Henry Holt Company Inc, United States (2004)
ISBN 10: 0805075089 ISBN 13: 9780805075083
New Paperback Quantity Available: 10
Seller:
Book Depository hard to find
(London, United Kingdom)
Rating
[?]

Book Description Henry Holt Company Inc, United States, 2004. Paperback. Condition: New. Reprint. Language: English . This book usually ship within 10-15 business days and we will endeavor to dispatch orders quicker than this where possible. Brand New Book. Tom Abate s reporting on biotechnology has always been ahead of the times. The Biotech Investor tackles the brave new world of stem cells, genomics, and clones and comes up a winner. --Thom Calandra, editor in chief, CBS MarketWatch In The Biotech Investor, San Francisco Chronicle biotechnology reporter Tom Abate explains the science, finances, time horizon, and technological and commercial potential of this burgeoning industry. Abate provides guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He shares strategies for - tracking the effect of breaking news and the NASDAQ - anticipating drug trial announcements and FDA approvals - assessing the potential market, patent rights, and distribution deals for a drug He looks beyond medicine to biotech-related opportunities in everything from agriculture to jean manufacturing to software development. The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century s most promising industries. Seller Inventory # BZE9780805075083

More information about this seller | Contact this seller

Buy New
US$ 20.43
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

8.

Tom Abate
ISBN 10: 0805075089 ISBN 13: 9780805075083
New Quantity Available: 5
Seller:
ReadWhiz
(Portland, OR, U.S.A.)
Rating
[?]

Book Description Condition: New. Seller Inventory # ria9780805075083_ing

More information about this seller | Contact this seller

Buy New
US$ 20.84
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

9.

Tom Abate
Published by Holt Paperbacks
ISBN 10: 0805075089 ISBN 13: 9780805075083
New Paperback Quantity Available: > 20
Seller:
BuySomeBooks
(Las Vegas, NV, U.S.A.)
Rating
[?]

Book Description Holt Paperbacks. Paperback. Condition: New. 304 pages. Dimensions: 8.4in. x 5.4in. x 0.9in.Tom Abates reporting on biotechnology has always been ahead of the times. The Biotech Investor tackles the brave new world of stem cells, genomics, and clones and comes up a winner. Thom Calandra, editor in chief, CBS MarketWatchIn The Biotech Investor, San Francisco Chronicle biotechnology reporter Tom Abate explains the science, finances, time horizon, and technological and commercial potential of this burgeoning industry. Abate provides guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He shares strategies for tracking the effect of breaking news and the NASDAQ anticipating drug trial announcements and FDA approvals assessing the potential market, patent rights, and distribution deals for a drugHe looks beyond medicine to biotech-related opportunities in everything from agriculture to jean manufacturing to software development. The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first centurys most promising industries. This item ships from multiple locations. Your book may arrive from Roseburg,OR, La Vergne,TN. Paperback. Seller Inventory # 9780805075083

More information about this seller | Contact this seller

Buy New
US$ 21.96
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

10.

Abate, Tom
Published by Holt Paperbacks (2004)
ISBN 10: 0805075089 ISBN 13: 9780805075083
New Paperback Quantity Available: 10
Seller:
Ergodebooks
(RICHMOND, TX, U.S.A.)
Rating
[?]

Book Description Holt Paperbacks, 2004. Paperback. Condition: New. Seller Inventory # INGM9780805075083

More information about this seller | Contact this seller

Buy New
US$ 19.11
Convert Currency

Add to Basket

Shipping: US$ 4.99
Within U.S.A.
Destination, Rates & Speeds

There are more copies of this book

View all search results for this book